相似文献
1
Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab.使用单次低剂量利妥昔单抗成功根除获得性凝血因子VIII抑制剂。
Haematologica. 2010 Mar;95(3):521-2. doi: 10.3324/haematol.2009.017749. Epub 2009 Nov 10.
2
Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy.获得性血友病A合并乙状结肠癌：利妥昔单抗治疗后行乙状结肠切除术取得成功。
Int J Hematol. 2009 Jul;90(1):33-36. doi: 10.1007/s12185-009-0347-9. Epub 2009 May 30.
3
Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.两例对标准治疗难治的获得性血友病患者对利妥昔单抗治疗反应良好。
Int J Hematol. 2008 Jun;87(5):545-549. doi: 10.1007/s12185-008-0077-4. Epub 2008 Apr 15.
4
Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor.
Geriatr Gerontol Int. 2009 Jun;9(2):197-9. doi: 10.1111/j.1447-0594.2008.00491.x.
5
[Efficiency of rituximab in acquired hemophilia: report of two cases and review of literature].[利妥昔单抗治疗获得性血友病的疗效：两例报告及文献复习]
Rev Med Interne. 2007 Dec;28(12):862-5. doi: 10.1016/j.revmed.2007.06.017. Epub 2007 Jul 25.
6
Rituximab in the treatment of adult acquired hemophilia A: a systematic review.
Crit Rev Oncol Hematol. 2007 Jul;63(1):47-52. doi: 10.1016/j.critrevonc.2006.11.004. Epub 2007 Jan 19.
7
Inhibitor eradication with rituximab in haemophilia: where do we stand?利妥昔单抗在血友病中清除抑制剂：我们处于什么位置？
Br J Haematol. 2014 Jun;165(5):600-8. doi: 10.1111/bjh.12829. Epub 2014 Mar 15.
8
Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature.利妥昔单抗和静脉注射免疫球蛋白（IVIG）治疗多发性骨髓瘤获得性因子 VIII 抑制剂：病例报告及文献复习。
Int J Hematol. 2012 Jan;95(1):102-6. doi: 10.1007/s12185-011-0968-7. Epub 2011 Dec 15.
9
Rituximab failure in a patient with allo-FVIII inhibitor.一名患有同种异体FVIII抑制剂的患者使用利妥昔单抗治疗失败。
Br J Haematol. 2006 Nov;135(3):412. doi: 10.1111/j.1365-2141.2006.06311.x. Epub 2006 Sep 15.
引用本文的文献
1
Rituximab for eradicating inhibitors in people with acquired haemophilia A.利妥昔单抗治疗获得性血友病 A 患者的抑制剂
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD011907. doi: 10.1002/14651858.CD011907.pub3.
2
Reduced-intensity, risk factor-stratified immunosuppression for acquired hemophilia A: single-center observational study.降低强度、基于风险因素分层的免疫抑制治疗获得性血友病 A：单中心观察性研究。
Ann Hematol. 2020 Sep;99(9):2105-2112. doi: 10.1007/s00277-020-04150-y. Epub 2020 Jul 3.
3
International recommendations on the diagnosis and treatment of acquired hemophilia A.国际上关于获得性血友病 A 的诊断和治疗建议。
Haematologica. 2020 Jul;105(7):1791-1801. doi: 10.3324/haematol.2019.230771. Epub 2020 May 7.
4
Rituximab for eradicating inhibitors in people with acquired haemophilia A.利妥昔单抗用于清除获得性甲型血友病患者体内的抑制物。
Cochrane Database Syst Rev. 2016 Jul 8;7(7):CD011907. doi: 10.1002/14651858.CD011907.pub2.
5
The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.抗CD20单克隆抗体利妥昔单抗治疗获得性血友病A。
Blood Transfus. 2016 May;14(2):255-61. doi: 10.2450/2015.0090-15. Epub 2015 Sep 3.
6
A Case of an Acquired Factor VIII Inhibitor Complicated by Multiple Treatment-Related Opportunistic Infections and Review of the Literature.1例获得性凝血因子VIII抑制物合并多种治疗相关机会性感染病例及文献复习
Case Rep Hematol. 2013;2013:703027. doi: 10.1155/2013/703027. Epub 2013 Dec 18.
7
Acquired Factor VIII Inhibitor: A Rare Etiology for Bruisability and Anemia.获得性凝血因子 VIII 抑制剂：导致易瘀伤和贫血的罕见病因。
Indian J Hematol Blood Transfus. 2013 Sep;29(3):178-80. doi: 10.1007/s12288-012-0174-7. Epub 2012 Jul 4.
8
An unusual cause of bleeding in an elderly patient.一位老年患者出血的不寻常原因。
Clin Med (Lond). 2012 Apr;12(2):150-2. doi: 10.7861/clinmedicine.12-2-150.
本文引用的文献
1
Cautions and caveats to the treatment of acquired hemophilia A.获得性血友病A治疗的注意事项及警示。
Haematologica. 2009 Aug;94(8):1181-2. doi: 10.3324/haematol.2009.011841.
2
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.获得性血友病A患者诊断和治疗的国际建议。
Haematologica. 2009 Apr;94(4):566-75. doi: 10.3324/haematol.2008.001743.
3
Autoimmune hemophilia at rescue.挽救性自身免疫性血友病
Haematologica. 2009 Apr;94(4):459-61. doi: 10.3324/haematol.2009.005777.
4
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.利妥昔单抗治疗HIV阴性患者后发生的进行性多灶性白质脑病：来自药物不良事件及报告项目研究的57例报告
Blood. 2009 May 14;113(20):4834-40. doi: 10.1182/blood-2008-10-186999. Epub 2009 Mar 5.
5
Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab.低剂量利妥昔单抗治疗慢性类固醇难治性移植物抗宿主病
Transplantation. 2008 Sep 27;86(6):875-9. doi: 10.1097/TP.0b013e318183f662.
6
Rituximab in the treatment of adult acquired hemophilia A: a systematic review.
Crit Rev Oncol Hematol. 2007 Jul;63(1):47-52. doi: 10.1016/j.critrevonc.2006.11.004. Epub 2007 Jan 19.
7
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.英国获得性血友病A：英国血友病中心医生组织进行的一项为期两年的全国性监测研究。
Blood. 2007 Mar 1;109(5):1870-7. doi: 10.1182/blood-2006-06-029850. Epub 2006 Oct 17.
8
A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
Thromb Haemost. 1993 Nov 15;70(5):753-7.
Zotero 插件